Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

High voriconazole target-site exposure after approved sequence dosing due to nonlinear pharmacokinetics assessed by long-term microdialysis.

Kirbs C, Kluwe F, Drescher F, Lackner E, Matzneller P, Weiss J, Zeitlinger M, Kloft C.

Eur J Pharm Sci. 2019 Feb 4. pii: S0928-0987(19)30054-5. doi: 10.1016/j.ejps.2019.02.001. [Epub ahead of print]

PMID:
30731238
2.

Insufficient harmonization of antibiotics assays - Polish experience with an external quality assessment program in the years 2011-2018.

Kowalski R, Ćwiklińska A, Lizakowski M, Kortas-Stempak B, Bednarczuk G, Fijałkowska A, Pikul P, Lewandowski K.

Clin Biochem. 2019 Feb 4. pii: S0009-9120(18)30693-3. doi: 10.1016/j.clinbiochem.2019.02.001. [Epub ahead of print]

PMID:
30731069
3.

Correction: Knowledge, perceptions and confidence of physicians and pharmacists towards pharmacogenetics practice in Kuwait.

PLOS ONE staff.

PLoS One. 2019 Feb 7;14(2):e0212118. doi: 10.1371/journal.pone.0212118. eCollection 2019.

4.

Digital Technology in Somatic and Gene Therapy Trials of Pediatric Patients With Ocular Diseases: Protocol for a Scoping Review.

Meinert E, Alturkistani A, Osama T, Halioua-Haubold CL, Car J, Majeed A, Wells G, MacLaren RE, Brindley D.

JMIR Res Protoc. 2019 Feb 7;8(2):e10705. doi: 10.2196/10705.

5.

Prediction of tacrolimus dosage in the early period after heart transplantation: a population pharmacokinetic approach.

Han Y, Zhou H, Cai J, Huang J, Zhang J, Shi SJ, Liu YN, Zhang Y.

Pharmacogenomics. 2019 Jan;20(1):21-35. doi: 10.2217/pgs-2018-0116. Epub 2018 Dec 6.

PMID:
30730287
6.

Integrated CYP2D6 interrogation for multiethnic copy number and tandem allele detection.

Qiao W, Martis S, Mendiratta G, Shi L, Botton MR, Yang Y, Gaedigk A, Vijzelaar R, Edelmann L, Kornreich R, Desnick RJ, Scott SA.

Pharmacogenomics. 2019 Jan;20(1):9-20. doi: 10.2217/pgs-2018-0135. Epub 2018 Dec 6.

PMID:
30730286
7.

Foreword: the year at Pharmacogenomics.

Jones S.

Pharmacogenomics. 2019 Jan;20(1):1. doi: 10.2217/pgs-2018-0190. No abstract available.

8.

Impact of NUDT15 genetics on severe thiopurine-related hematotoxicity in patients with European ancestry.

Schaeffeler E, Jaeger SU, Klumpp V, Yang JJ, Igel S, Hinze L, Stanulla M, Schwab M.

Genet Med. 2019 Feb 7. doi: 10.1038/s41436-019-0448-7. [Epub ahead of print]

PMID:
30728528
9.

Association of Diabetes and Glycated Hemoglobin With the Risk of Intracerebral Hemorrhage: A Population-Based Cohort Study.

Saliba W, Barnett-Griness O, Gronich N, Molad J, Naftali J, Rennert G, Auriel E.

Diabetes Care. 2019 Feb 6. pii: dc182472. doi: 10.2337/dc18-2472. [Epub ahead of print]

PMID:
30728223
10.

Metronidazole induced cerebellar dysfunction: A dose related phenomenon or a pharmacogenetic outcome?

Kaur U, Kumar I, Singh A, Kumar M, Chakrabarti SS.

Curr Drug Saf. 2019 Feb 6. doi: 10.2174/1574886314666190206154735. [Epub ahead of print]

PMID:
30727914
11.

Pharmaceutical product development exploiting 3D printing technology: Conventional to novel drug delivery system.

Alam MS, Akhtar A, Ahsan I, Shafiq-Un-Nabi S.

Curr Pharm Des. 2019 Feb 6. doi: 10.2174/1381612825666190206195808. [Epub ahead of print]

PMID:
30727872
12.

The N-recognin UBR4 of the N-end rule pathway is required for neurogenesis and homeostasis of cell surface proteins.

Kim ST, Lee YJ, Tasaki T, Hwang J, Kang MJ, Yi EC, Kim BY, Kwon YT.

PLoS One. 2018 Aug 29;13(8):e0202260. doi: 10.1371/journal.pone.0202260. eCollection 2018.

13.

Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study.

Perlis RH, Mehta R, Edwards AM, Tiwari A, Imbens GW.

Depress Anxiety. 2018 Oct;35(10):946-952. doi: 10.1002/da.22742. Epub 2018 May 7.

PMID:
29734486
14.

Toward personalized medicine for intrahepatic cholangiocarcinoma: Pharmacogenomic stratification of patients.

Olaizola P, Perugorria MJ, Banales JM.

Hepatology. 2018 Sep;68(3):811-814. doi: 10.1002/hep.29830. Epub 2018 May 14. No abstract available.

PMID:
29394502
15.

Analysis of Fusion Genes by NanoString System: A Role in Lung Cytology?

Alì G, Bruno R, Savino M, Giannini R, Pelliccioni S, Menghi M, Boldrini L, Proietti A, Chella A, Ribechini A, Fontanini G.

Arch Pathol Lab Med. 2018 Apr;142(4):480-489. doi: 10.5858/arpa.2017-0135-RA. Epub 2018 Jan 26. Review.

PMID:
29372843
16.

Enhanced antitumor and anti-metastasis efficacy against aggressive breast cancer with a fibronectin-targeting liposomal doxorubicin.

Jiang K, Song X, Yang L, Li L, Wan Z, Sun X, Gong T, Lin Q, Zhang Z.

J Control Release. 2018 Feb 10;271:21-30. doi: 10.1016/j.jconrel.2017.12.026. Epub 2017 Dec 23.

PMID:
29277681
17.

Pharmacogenomic Advances in the Prediction and Prevention of Cutaneous Idiosyncratic Drug Reactions.

Pan RY, Dao RL, Hung SI, Chung WH.

Clin Pharmacol Ther. 2017 Jul;102(1):86-97. doi: 10.1002/cpt.683. Epub 2017 Jun 3. Review.

PMID:
28295240
18.

Cost Evaluation of Irinotecan-Related Toxicities Associated With the UGT1A1*28 Patient Genotype.

Roncato R, Cecchin E, Montico M, De Mattia E, Giodini L, Buonadonna A, Solfrini V, Innocenti F, Toffoli G.

Clin Pharmacol Ther. 2017 Jul;102(1):123-130. doi: 10.1002/cpt.615. Epub 2017 Mar 20.

PMID:
28074472
19.

Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.

McKillip RP, Borden BA, Galecki P, Ham SA, Patrick-Miller L, Hall JP, Hussain S, Danahey K, Siegler M, Sorrentino MJ, Sacro Y, Davis AM, Rubin DT, Lipstreuer K, Polonsky TS, Nanda R, Harper WR, Koyner JL, Burnet DL, Stadler WM, Ratain MJ, Meltzer DO, O'Donnell PH.

Clin Pharmacol Ther. 2017 Jul;102(1):106-114. doi: 10.1002/cpt.586. Epub 2017 Apr 4.

Supplemental Content

Loading ...
Support Center